Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000358,serum insulin level,,,,0.000222,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67475,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood free fatty acid amount,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000547,serum free fatty acids level,,,,0.67,mmol/l,0.067,0.1773,MMO:0000308,serum free fatty acid analysis,,0.0,"Wako Pure Chemicals, Tokyo, Japan",,,days,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67495,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",epididymal fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000658,epididymal fat pad weight to body weight ratio,,,,2.63,%,0.16,0.4233,MMO:0000005,post excision weight measurement,,0.0,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67491,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",retroperitoneal fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000635,retroperitoneal fat pad weight to body weight ratio,,,,2.19,%,0.18,0.4762,MMO:0000005,post excision weight measurement,,0.0,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67471,specific pathogen-free condition (for 210 days),fasting (for 1 days), 41,NBRP Organ Weight data,lung mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000097,lung wet weight,,,,0.848,g,0.0192,0.047,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71829,specific pathogen-free condition,, 41,NBRP Organ Weight data,spleen mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000149,spleen weight to body weight ratio,,,,0.219,%,0.0041,0.01,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71838,specific pathogen-free condition,, 22,NBRP Body Temperature data,body temperature trait,,RS:0000364,F344/NSlc,male,70 days to 56 days,6,,CMO:0000015,body temperature,,,serial mean,37.9,degrees C,0.1225,0.3,MMO:0000034,digital rectal thermometry,,,,,,,specific pathogen-free condition,74987,specific pathogen-free condition,, 41,NBRP Organ Weight data,kidney mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000140,both kidneys wet weight as percentage of body weight,,,,0.612,%,0.0078,0.019,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71834,specific pathogen-free condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",retroperitoneal fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000356,retroperitoneal fat pad weight,,,,8.7,g,0.8,2.1166,MMO:0000005,post excision weight measurement,,,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12781,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000046,blood glucose level,,,,78,mg/dl,2.6,6.879,MMO:0000113,oral glucose tolerance test,,0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12770,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,149,mg/dl,3.52,9.313,MMO:0000113,oral glucose tolerance test,,0,,oral dose,120,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13160,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,157,mg/dl,5.21,13.7844,MMO:0000113,oral glucose tolerance test,,0,,oral dose,60,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13159,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,149.1,mg/dl,4.2,11.1122,MMO:0000113,oral glucose tolerance test,,0,,oral dose,30,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13158,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,134.1,mg/dl,4.7,12.435,MMO:0000113,oral glucose tolerance test,,0,,oral dose,15,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13157,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,99,mg/dl,4.48,11.853,MMO:0000113,oral glucose tolerance test,,0,,oral dose,0,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13156,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 41,NBRP Organ Weight data,brain mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000139,brain weight to body weight ratio,,,,0.843,%,0.0073,0.018,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71826,specific pathogen-free condition,, 41,NBRP Organ Weight data,liver mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000141,liver weight as percentage of body weight,,,,3.063,%,0.029,0.071,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71832,specific pathogen-free condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000360,serum triglyceride level,,,,108.4,mg/dl,14.5,38.3634,MMO:0000136,serum triglyceride analysis,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13192,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",mesenteric fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000355,mesenteric fat pad weight,,,,7,g,0.7,1.852,MMO:0000005,post excision weight measurement,,,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12780,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood cholesterol amount,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000363,serum total cholesterol level,,,,69.7,mg/dl,1.77,4.683,MMO:0000132,serum total cholesterol measurement test,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12775,specific pathogen-free condition (for 210 days),fasting (for 1 days), 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000364,F344/NSlc,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,149,mmHg,6.532,16.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74985,specific pathogen-free condition,, 41,NBRP Organ Weight data,lung mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000156,lung weight to body weight ratio,,,,0.391,%,0.0086,0.021,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71830,specific pathogen-free condition,, 41,NBRP Organ Weight data,liver mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000158,liver wet weight,,,,6.647,g,0.1045,0.256,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71831,specific pathogen-free condition,, 41,NBRP Organ Weight data,adrenal gland mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000164,both adrenal glands wet weight,,,,45.7,mg,0.8981,2.2,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71835,specific pathogen-free condition,, 14,NBRP Blood Pressure and Heart Rate data,heart pumping trait,,RS:0000364,F344/NSlc,male,70 days to 56 days,6,,CMO:0000002,heart rate,,,serial mean,449,beats/min,17.9629,44.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74986,specific pathogen-free condition,, 41,NBRP Organ Weight data,brain mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000155,brain wet weight,,,,1.829,g,0.0106,0.026,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71825,specific pathogen-free condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",epididymal fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000357,epididymal fat pad weight,,,,10.4,g,0.7,1.852,MMO:0000005,post excision weight measurement,,,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12782,specific pathogen-free condition (for 210 days),fasting (for 1 days), 41,NBRP Organ Weight data,heart mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000069,heart wet weight,,,,0.728,g,0.0237,0.058,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71827,specific pathogen-free condition,, 41,NBRP Organ Weight data,kidney mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000085,both kidneys wet weight,,,,1.329,g,0.0216,0.053,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71833,specific pathogen-free condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000012,body weight,,,,393.6,g,6.2,16.4037,MMO:0000016,body weighing method,,,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12785,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",body mass,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000012,body weight,,,,470.3,g,9.59,25.3728,MMO:0000016,body weighing method,,0,,,,,specific pathogen-free condition then fasting (for 16 hours),11607,specific pathogen-free condition,fasting (for 16 hours), 41,NBRP Organ Weight data,testis mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000175,both testes wet weight,,,,2.588,g,0.0294,0.072,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71839,specific pathogen-free condition,, 41,NBRP Organ Weight data,testis mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000901,both testes wet weight to body weight ratio,,,,1.193,%,0.0171,0.042,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71840,specific pathogen-free condition,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",mesenteric fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000654,mesenteric fat pad weight to body weight ratio,,,,1.77,%,0.15,0.3969,MMO:0000005,post excision weight measurement,,0.0,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67467,specific pathogen-free condition (for 210 days),fasting (for 1 days), 41,NBRP Organ Weight data,spleen mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000171,spleen wet weight,,,,0.475,g,0.0131,0.032,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71837,specific pathogen-free condition,, 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000350,blood glucose level area under curve (AUC),,,,1.8,(mg/dl) x min,0.52,1.3758,MMO:0000113,oral glucose tolerance test,,0,trapezoid rule used for calculation,oral dose,,,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,11606,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood adiponectin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000583,serum adiponectin level,,,,3.28,ng/ml,0.3,0.7937,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67479,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000780,serum leptin level,,,,5.46,ng/ml,1.06,2.8045,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67483,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 41,NBRP Organ Weight data,adrenal gland mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000621,both adrenal glands weight to body weight ratio,,,,21.1,mg/100g,0.5307,1.3,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71836,specific pathogen-free condition,, 21,NBRP Body Weight data,body mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000012,body weight,,,,233.2,g,3.3476,8.2,MMO:0000017,whole body digital scale,,,,,,,specific pathogen-free condition,70731,specific pathogen-free condition,, 21,NBRP Body Weight data,body mass,,RS:0000364,F344/NSlc,male,42 days,6,,CMO:0000012,body weight,,,,126.1,g,1.5922,3.9,MMO:0000017,whole body digital scale,,,,,,,specific pathogen-free condition,70732,specific pathogen-free condition,, 21,NBRP Body Weight data,body mass,,RS:0000364,F344/NSlc,male,35 days,6,,CMO:0000012,body weight,,,,80.8,g,0.939,2.3,MMO:0000017,whole body digital scale,,,,,,,specific pathogen-free condition,70733,specific pathogen-free condition,, 41,NBRP Organ Weight data,heart mass,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000074,heart weight to body weight ratio,,,,3.36,g/kg,0.1143,0.28,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71828,specific pathogen-free condition,,